meta-analysis | Q815382 |
scholarly article | Q13442814 |
P50 | author | Paolo Fusar-Poli | Q21094931 |
Philip McGuire | Q37834611 | ||
Alison R. Yung | Q37835108 | ||
Lucia Valmaggia | Q42823642 | ||
Barnaby Nelson | Q62583760 | ||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk | Q27002449 | ||
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
Klaus Conrad (1905-1961): delusional mood, psychosis, and beginning schizophrenia | Q33566183 | ||
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. | Q33775024 | ||
Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis. | Q33950926 | ||
Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder | Q34010659 | ||
Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders | Q34124435 | ||
Cognitive functioning in prodromal psychosis: a meta-analysis | Q34278910 | ||
Global assessment of functioning. A modified scale | Q34302424 | ||
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States | Q34475129 | ||
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America | Q34586836 | ||
Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults | Q34604368 | ||
Should attenuated psychosis syndrome be included in DSM-5? | Q34635905 | ||
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk | Q34636460 | ||
At clinical high risk for psychosis: outcome for nonconverters | Q35148454 | ||
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research | Q35768192 | ||
Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis | Q35768219 | ||
Introduction: The extended psychosis phenotype--relationship with schizophrenia and with ultrahigh risk status for psychosis. | Q35768254 | ||
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. | Q35873850 | ||
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis | Q35903811 | ||
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies | Q36386404 | ||
Risk factors for psychosis: impaired social and role functioning | Q36386414 | ||
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder | Q37208950 | ||
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. | Q37224904 | ||
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study | Q37310198 | ||
Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. | Q37781124 | ||
The psychosis high-risk state: a comprehensive state-of-the-art review | Q38061036 | ||
Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life | Q44974332 | ||
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis | Q46762892 | ||
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis | Q48394255 | ||
Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries | Q48705979 | ||
Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. | Q50803831 | ||
The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder | Q51695488 | ||
Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? | Q51828879 | ||
Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. | Q51862013 | ||
Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. | Q51873130 | ||
PACE: a specialised service for young people at risk of psychotic disorders. | Q51896853 | ||
Association between psychotic experiences and depression in a clinical sample over 6 months. | Q51907815 | ||
Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. | Q51928424 | ||
Is our concept of schizophrenia influenced by Berkson's bias? | Q51938411 | ||
Reduced subjective quality of life in persons at risk for psychosis. | Q53159612 | ||
Lost in transition: setting the psychosis threshold in prodromal research | Q53961984 | ||
Limitations of the Application of Fourfold Table Analysis to Hospital Data | Q56503537 | ||
Disability in people clinically at high risk of psychosis | Q60445896 | ||
The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid? | Q60545829 | ||
Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia | Q78236834 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anxiety | Q154430 |
psychosis | Q170082 | ||
P304 | page(s) | 120-131 | |
P577 | publication date | 2012-11-22 | |
P1433 | published in | Schizophrenia Bulletin | Q4049133 |
P1476 | title | Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis | |
P478 | volume | 40 |
Q96034543 | "I don't think I took her fears seriously." Exploring the experiences of family members of individuals at-risk of developing psychosis over 12-months |
Q90752929 | 'At risk mental state' clinics for psychosis - an idea whose time has come - and gone! |
Q52317815 | 'False-positive' self-reported psychotic experiences in the general population: an investigation of outcome, predictive factors and clinical relevance. |
Q92862585 | A Mentalization-Informed Staging Approach to Clinical High Risk for Psychosis |
Q33670654 | A critique of the "ultra-high risk" and "transition" paradigm |
Q47668934 | A longitudinal mediation analysis of the effect of negative-self-schemas on positive symptoms via negative affect. |
Q38660807 | A qualitative phenomenological analysis of the subjective experience and understanding of the at risk mental state |
Q37540848 | A randomized trial of family focused therapy with populations at clinical high risk for psychosis: effects on interactional behavior |
Q38819011 | A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis |
Q40084185 | A systematic review and meta-analysis of mental health service use in people who report psychotic experiences. |
Q96640306 | Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis |
Q47562372 | Addiction Vulnerability: Exploring Relationships Between Cigarette Smoking, Substance Misuse and Early Psychosis. |
Q89667017 | Advances in clinical staging, early intervention, and the prevention of psychosis |
Q26741515 | Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment |
Q48043070 | All that glitters is not gold: prevalence and relevance of psychotic-like experiences in clinical sample of children and adolescents aged 8-17 years old. |
Q30381309 | Alterations in the hippocampus and thalamus in individuals at high risk for psychosis. |
Q45839278 | Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis |
Q43073835 | An Overview of Recent Findings on Social Anxiety Disorder in Adolescents and Young Adults at Clinical High Risk for Psychosis. |
Q57519639 | Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study |
Q38611406 | Anxiety in Patients with Schizophrenia: Epidemiology and Management |
Q37017300 | Anxiety in youth at clinical high risk for psychosis |
Q48068643 | Applicability of the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) for identifying attenuated psychosis syndrome in a college population |
Q38258292 | Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis. |
Q39153105 | Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk. |
Q37622280 | Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures. |
Q60639098 | Association of Primary Care Consultation Patterns With Early Signs and Symptoms of Psychosis |
Q93369149 | Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis |
Q36118724 | At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction |
Q38114968 | Attenuated psychosis syndrome in DSM-5. |
Q46228189 | Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort |
Q44627179 | Behavioural activation therapy for adolescents 'at risk' for psychosis? |
Q38826685 | Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis |
Q91669884 | Borderline Personality Pathology in an At Risk Mental State Sample |
Q48089122 | Borderline personality pathology in young people at ultra high risk of developing a psychotic disorder |
Q90361881 | Breaking the web: life beyond the at-risk mental state for psychosis |
Q47604884 | Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk |
Q50041332 | Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders. |
Q47316102 | Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis |
Q47836760 | Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators |
Q26770197 | Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis |
Q37710469 | Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis |
Q33762519 | Characterization of psychotic experiences in adolescence using the specific psychotic experiences questionnaire: findings from a study of 5000 16-year-old twins. |
Q90926751 | Childhood adversities in people at ultra-high risk (UHR) for psychosis: a systematic review and meta-analysis |
Q92699971 | Childhood temperament is associated with distress, anxiety and reduced quality of life in schizophrenia spectrum disorders |
Q90128803 | Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project |
Q47621148 | Clinical high risk for psychosis in children and adolescents: a systematic review |
Q48088952 | Clinical high risk for psychosis: gender differences in symptoms and social functioning |
Q58613991 | Combined cognitive, psychomotor and electrophysiological biomarkers in major depressive disorder |
Q30380217 | Common and divergent psychobiological mechanisms underlying maternal behaviors in non-human and human mammals |
Q47721523 | Common mental disorder including psychotic experiences: Trailblazing a new recovery pathway within the Improving Access to Psychological Therapies programme in England |
Q45159123 | Comorbid Mental Disorders and 6-Month Symptomatic and Functioning Outcomes in Chinese University Students at Clinical High Risk for Psychosis |
Q27015872 | Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment |
Q92105678 | Comorbid Personality Disorders in Individuals With an At-Risk Mental State for Psychosis: A Meta-Analytic Review |
Q46819894 | Comorbid diagnoses for youth at clinical high risk of psychosis |
Q42052463 | Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors |
Q58576623 | Coproducing healthcare service improvement for people with common mental health disorders including psychotic experiences: a study protocol of a multiperspective qualitative study |
Q50420782 | Core beliefs in healthy youth and youth at ultra high-risk for psychosis: Dimensionality and links to depression, anxiety, and attenuated psychotic symptoms |
Q30993265 | Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy |
Q47837277 | Course of clinical high-risk states for psychosis beyond conversion |
Q46365588 | Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review. |
Q34123531 | Current status specifiers for patients at clinical high risk for psychosis |
Q38898192 | Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue? |
Q47841045 | Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. |
Q41068640 | Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project |
Q35096522 | Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers |
Q47862021 | Developing and Validating a Computerized Adaptive Test to Measure Broad and Specific Factors of Internalizing in a Community Sample |
Q38868964 | Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis. |
Q38980241 | Development of self-inflicted injury: Comorbidities and continuities with borderline and antisocial personality traits |
Q92132960 | Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia |
Q26795451 | Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis |
Q40051964 | Do fewer males present to clinical high-risk services for psychosis relative to first-episode services? |
Q47417241 | Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome |
Q64261741 | Early Somatosensory Processing Over Time in Individuals at Risk to Develop Psychosis |
Q48527862 | Early referral and comorbidity as possible causes of the declining transition rate in subjects at clinical high risk for psychosis |
Q30397626 | Effect of acute swim stress on plasma corticosterone and brain monoamine levels in bidirectionally selected DxH recombinant inbred mouse strains differing in fear recall and extinction |
Q95307226 | Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis |
Q64267299 | Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis |
Q52559088 | Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome. |
Q47908228 | Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience. |
Q40266004 | Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology. |
Q35040094 | Evidence that transition from health to psychotic disorder can be traced to semi-ubiquitous environmental effects operating against background genetic risk |
Q38254790 | Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis |
Q36071272 | Exposure to environmental factors increases connectivity between symptom domains in the psychopathology network |
Q90392421 | Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes |
Q30881360 | Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program. |
Q39905473 | Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. |
Q38879526 | Genetic Overlap Between Schizophrenia and Developmental Psychopathology: Longitudinal and Multivariate Polygenic Risk Prediction of Common Psychiatric Traits During Development |
Q39432209 | Guidelines for the Pharmacotherapy of Schizophrenia in Adults |
Q35759415 | Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication |
Q36542913 | INCREASED INTERNET USE AND POORER ABILITY TO MANAGE EMOTIONS IN YOUTH AT HIGH-RISK FOR PSYCHOSIS |
Q48201789 | Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility study |
Q47708592 | Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study |
Q42376197 | Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms |
Q42315776 | Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms. |
Q50460088 | Implication of reward alterations in the expression of negative symptoms in 22q11.2 deletion syndrome: a behavioural and DTI study. |
Q31122156 | Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation |
Q41658737 | Improving outcomes of first-episode psychosis: an overview |
Q47222599 | Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort. |
Q38758518 | Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS). |
Q57031589 | Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation |
Q57145351 | Interpersonal processes in paranoia: a systematic review |
Q50596157 | Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis. |
Q47620192 | Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence |
Q97517737 | Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study |
Q35739838 | Intrinsic Functional Connectivity in Salience and Default Mode Networks and Aberrant Social Processes in Youth at Ultra-High Risk for Psychosis |
Q47596285 | Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups |
Q36148454 | Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study |
Q89086766 | Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk |
Q53424592 | Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). |
Q47677681 | Measuring mental health in the clinical setting: what is important to service users? The Mini-Service user Recovery Evaluation scale (Mini-SeRvE). |
Q47563530 | Mediators Linking Childhood Adversities and Trauma to Suicidality in Individuals at Risk for Psychosis. |
Q40333875 | Modeling the Interplay Between Psychological Processes and Adverse, Stressful Contexts and Experiences in Pathways to Psychosis: An Experience Sampling Study |
Q36111457 | Neural correlates of aberrant emotional salience predict psychotic symptoms and global functioning in high-risk and first-episode psychosis |
Q35140476 | Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up |
Q35928509 | Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis |
Q91705551 | Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature |
Q47276081 | Non-Suicidal Self-Injury in Pediatric Bipolar Disorder: Clinical Correlates and Impact on Psychosocial Treatment Outcomes. |
Q38191255 | Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function |
Q99402426 | Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis |
Q60625022 | Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis |
Q47243786 | Peer status in relation to psychotic experiences and psychosocial problems in adolescents: a longitudinal school-based study |
Q47651190 | Perceptual abnormalities in an ultra-high risk for psychosis population relationship to trauma and co-morbid disorder |
Q37258886 | Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population |
Q47411862 | Physical health promotion for young people at ultra-high risk for psychosis: An application of the COM-B model and behaviour-change wheel. |
Q39824871 | Polish individuals with an at-risk mental state: demographic and clinical characteristics |
Q48016695 | Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity |
Q56876569 | Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression |
Q91432385 | Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator |
Q64990683 | Predictors of Lifetime Suicide Attempts in Individuals With Attenuated Psychosis Syndrome. |
Q41321845 | Prisoners at ultra-high-risk for psychosis: a cross-sectional study. |
Q35639344 | Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study |
Q100454919 | Progression from being at-risk to psychosis: next steps |
Q39177987 | Progression from unipolar depression to schizophrenia |
Q37098386 | Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis |
Q64282103 | Psychological interventions for people with psychotic experiences: protocol for a systematic review and meta-analysis |
Q39153390 | Psychotic experiences and psychological distress predict contemporaneous and future non-suicidal self-injury and suicide attempts in a sample of Australian school-based adolescents |
Q90218602 | Rationale, Methods, Feasibility, and Preliminary Outcomes of a Transdiagnostic Prevention Program for At-Risk College Students |
Q91218920 | Reasoning bias, working memory performance and a transdiagnostic phenotype of affective disturbances and psychotic experiences in the general population |
Q37589487 | Reconsidering Clinical Staging Model: A Case of Genetic High Risk for Schizophrenia |
Q47563160 | Relationship between metacognitive beliefs and psychosocial performance in at-risk states of psychosis and patients with first psychotic episodes |
Q37696740 | Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis |
Q35624912 | Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders |
Q88407120 | Resting state connectivity dynamics in individuals at risk for psychosis |
Q41656821 | Sex differences in morning cortisol in youth at ultra-high-risk for psychosis. |
Q44666926 | Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia |
Q37183961 | Shared Etiology of Psychotic Experiences and Depressive Symptoms in Adolescence: A Longitudinal Twin Study. |
Q64257794 | Social Mindfulness and Psychosis: Neural Response to Socially Mindful Behavior in First-Episode Psychosis and Patients at Clinical High-Risk |
Q57170494 | Social reward processing: A biomarker for predicting psychosis risk? |
Q35950862 | Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis |
Q36817265 | Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study |
Q92202540 | Stress perception following childhood adversity: Unique associations with adversity type and sex |
Q39310306 | Stress sensitivity as a putative mechanism linking childhood trauma and psychopathology in youth's daily life. |
Q94561042 | Study Protocol for a Prospective Longitudinal Cohort Study to Identify Proteomic Predictors of Pluripotent Risk for Mental Illness: The Seoul Pluripotent Risk for Mental Illness Study |
Q30491259 | Subclinical psychotic experiences and subsequent contact with mental health services. |
Q41590809 | Suicidality, self-harm and psychotic-like symptoms in a general adolescent psychiatric sample |
Q36223560 | The Reliability and Validity of Liu´s Self-Report Questionnaire for Screening Putative Pre-Psychotic States (BQSPS) in Adolescents |
Q33581212 | The Role of Trauma and Stressful Life Events among Individuals at Clinical High Risk for Psychosis: A Review |
Q47782985 | The association between sleep dysfunction and psychosis-like experiences among college students. |
Q47585327 | The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group |
Q90133833 | The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness |
Q92202461 | The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling |
Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
Q47832927 | The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis |
Q37182953 | The role of rumination in illness trajectories in youth: linking trans-diagnostic processes with clinical staging models. |
Q39760221 | Theory of Mind Impairments in Youth at Clinical High Risk of Psychosis |
Q36995932 | Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS |
Q35096541 | Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project |
Q91214238 | TwinssCan - Gene-Environment Interaction in Psychotic and Depressive Intermediate Phenotypes: Risk and Protective Factors in a General Population Twin Sample |
Q89061238 | Using Online Screening in the General Population to Detect Participants at Clinical High-Risk for Psychosis |
Q90570746 | Validation of the Korean Version of the 15-Item Community Assessment of Psychic Experiences in a College Population |
Q92895356 | What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors |
Q52660954 | Youth Mental Health Should Be a Top Priority for Health Care in Canada. |
Search more.